Raymond James Sees Marathon Stock Poised for 270 Target
Raymond James raises Marathon's target to 270, driven by sustained refining margins and strong MPLX distributions. MP...
This volatility comparison pits the dividend aristocrats ETF against the SP500 to help you evaluate relative risk and inform allocation decisions.
20,523 articlesRaymond James raises Marathon's target to 270, driven by sustained refining margins and strong MPLX distributions. MP...
Investing in healthcare in 2026 means choosing between stability and potential high growth. This original guide weigh...
As investors await gatx (gatx) 2025 earnings, this guide breaks down what to watch in the quarterly results, how the ...
With whispers of funded shortfalls, retirees social security just may face tighter benefits. This guide breaks down w...
As rates stay elevated and markets shift, retirees are rethinking how to fund living costs without eroding the inheri...
When big defense deals surface, Lockheed Martin stock often reacts. This piece breaks down why lockheed martin stock ...
Looking ahead to 2026, investors want a clear view of how Global Partners will navigate energy markets, margins, and ...
Novo Nordisk faces challenges, but three strong catalysts could propel the stock higher. This article breaks down the...
Investors are watching Nomad Foods navigate a tough year. While the stock has fallen, there are hidden strengths and ...
A growing number of savers are adopting a three-bucket income strategy to generate roughly $60,000 a year from divide...
Market mood slides while retail spend stays resilient. Three beaten-down consumer stocks july look poised for catalys...
MSTU, a 2x daily ETF linked to MSTR, has endured a brutal period as the underlying stock and crypto markets gyrate, s...